double dose of tirzepatide In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Early Dose Escalation of Tirzepatide

Lets break down the science, real-world timelines, and what you can expect week by week no hype, just honest insight

A 2019 study in Surgery for Obesity and Related Diseases (Ciangura et al.) tracked menstrual changes in 240 women post-gastric bypass and found 68% reported heavier or irregular periods in months 2 to 6 post-surgery, with normalization by month 9 to 12 as weight loss plateaued

Whilst night sweats are not listed as an official adverse effect in the Summary of Product Characteristics, some patients have reported nocturnal perspiration whilst taking this medication

Opens in a new tab Overgaard, R.V., et al